Company / Net Income
Phathom Pharmaceuticals, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$221.2M
FY2025
5-year range
-$221.2M / -$143.9M
FY2021-FY2025
Trend
-9.7%
vs FY2024
Sector context
#161 of 216
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s net income of -$221M is lower than 75% of companies in the Health Care sector (FY2025). Declined from -$202M to -$221M over the past 2 years.
Based on SEC 10-K filings.
-$221M in FY2025.
Declined from -$202M to -$221M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 216This company -$221.2M Sector average $454.1M
▼
-148.7% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 9.7% year-over-year.
- Ranks #161 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
- Lowest net income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$221.2M | -9.7% |
| FY2024 | -$201.6M | +0.0% |
| FY2023 | -$201.6M | -2.0% |
| FY2022 | -$197.7M | -37.4% |
| FY2021 | -$143.9M | -11.5% |
| FY2020 | -$129.1M | +49.4% |
| FY2019 | -$255.1M | -19708.3% |
| FY2018 | -$1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026